Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shacondra M. Johnson"'
Autor:
Edward W. Hook, Byron E. Batteiger, Arlene C. Seña, Stephanie N. Taylor, Shacondra M. Johnson, Kenneth Lawrence, Michael R. Wierzbicki, Jill Long, Jeanne M. Marrazzo, John P. Mueller, Hannah Kwak
Publikováno v:
The New England journal of medicine. 379(19)
Antibiotic-resistant Neisseria gonorrhoeae has prompted the development of new therapies. Zoliflodacin is a new antibiotic that inhibits DNA biosynthesis. In this multicenter, phase 2 trial, zoliflodacin was evaluated for the treatment of uncomplicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4ab621bd96a81ce19db4f30fbf9d1c
https://pubmed.ncbi.nlm.nih.gov/30514967
https://pubmed.ncbi.nlm.nih.gov/30514967
Autor:
Edward W. Hook, Shacondra M. Johnson, Stephanie N. Taylor, Arlene C. Seña, Hannah Kwak, Kenneth Lawrence, Michael R. Wierzbicki, Jeanne Marazzo, Byron E. Batteiger, John D. Mueller
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::934a9cc93bc2f763922ab8559bd64a61
https://doi.org/10.1093/ofid/ofw172.1011
https://doi.org/10.1093/ofid/ofw172.1011
Autor:
Raymond C.W. Perry, Shacondra M. Johnson, Carmel M. Kadrnka, William M. Geisler, Jeannette Y. Lee, Shelly Lensing, Peter R. Kerndt, Apurva Uniyal
Publikováno v:
The New England journal of medicine, vol 373, iss 26
BackgroundUrogenital Chlamydia trachomatis infection remains prevalent and causes substantial reproductive morbidity. Recent studies have raised concern about the efficacy of azithromycin for the treatment of chlamydia infection.MethodsWe conducted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774ab22aa22f2a70418615627750ffdb
https://europepmc.org/articles/PMC4708266/
https://europepmc.org/articles/PMC4708266/
Autor:
Robert D. Kirkcaldy, Shacondra M. Johnson, Alesia Harvey, Jonathan M. Zenilman, Connie Lenderman, Abi Jett, Kevin Pettus, Carol L. Priest, Jeannette Y. Lee, Shannon Fuller, Amelia Herrera, Samera Sharpe, Jennifer Vonghack, Harold C. Wiesenfeld, Susan S. Philip, Linda McNeil, Carolyn D. Deal, Nikole Trainor, Ingrid Macio, Jonathan Glock, Shelly Lensing, Deborah Dowell, Lalitha Venkatasubramanian, Khalil G. Ghanem, Jonathan S. Carlson, Marisol Mejia, Jill Long, Peter R. Kerndt, Tracy E. Campbell, Allison Whittington, Hillard Weinstock, Edward W. Hook, Lori M. Newman, LaShawnda Royal, Apurva Uniyal, Page C. Moore, Susan Tobias, Paula Dixon, John R. Papp, Hanne S. Harbison, Charlotte Perlowski
Background. Ceftriaxone is the foundation of currently recommended gonorrhea treatment. There is an urgent need for backup treatment options for patients with cephalosporin allergy or infections due to suspected cephalosporin-resistant Neisseria gono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c67e30837b3e7059c539015c1c6d2cb
https://europepmc.org/articles/PMC4271098/
https://europepmc.org/articles/PMC4271098/